Biotech

Lured by the state's tax credits for investments in high-growth companies, a Minneapolis biotech start-up said Thursday that it was moving to Wisconsin. VitalMedix Inc. is developing a drug that first responders, trauma center surgeons and military medics could use. The drug, Tamiasyn, has the potential...

MADISON - ProCertus BioPharm, Inc., an oncology-based pharmaceutical company developing therapeutics to protect cancer patients from the side effects of radiotherapy and chemotherapy, announced that its collaborators at the University of Wisconsin - Madison have begun enrolling patients in a clinical trial designed to determine...

Hundreds of embryonic stem cell lines, whose use in the United States had effectively been curtailed by the Bush administration, can be used to study disorders and develop cures if researchers can show the cells were derived using ethical procedures, according to new rules issued...

A committee of UW-Madison officials recently selected the five research themes and faculty leaders that will guide UW-Madison’s new research facility, the Wisconsin Institute for Discovery. The institute, which is currently under construction on University Avenue, will focus on research intended to improve human health. The...

Alnylam leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to rise. BioHealth Investor began by analyzing 171 stocks in the biotech sector based on revenue growth over the trailing four quarters, identifying 30 stocks in the sector with...

BROTHERTOWN, Wis. - The corn crop sprouting on Bill Hansen's 150-acre farm in Calumet County has a secret: It's fortified with special traits at the microscopic level. Advertisement Quantcast Such genetic alterations begin with the corn seed, which allows it to grow into a plant resistant to...

It sounds like something from a science fiction movie: Sensors are surgically inserted in the brain to understand what you're thinking. Machines that can speak, move or process information — based on the fleeting thoughts in a person's imagination. But it's not completely fictional. The technology...

Biotechnology start-ups have long relied on grants from the National Institutes of Health to fund the research-and-development process for new drugs, medical devices and disease treatments. Every year, the agency is required by law to set aside 2.8 percent of its research budget -- $650...

According to a report in FierceBiotech, surprising news came out of the recently completed 45th Annual Meeting of the Drug Information Association (DIA). Despite cutbacks in the international biopharma industry, clinical trial activity was up in 2008. Overall, 795 new clinical trials were launched...